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Abstract Malaria is the most important parasitic disease,
leading to annual death of about one million people and the
Plasmodium falciparum develops resistant to well-estab-
lished antimalarial drugs. The newest antiplasmodial drug
from metal oxide nanoparticles helps in addressing this
problem. Commercial nanoparticles such as Fe3O4, MgO,
ZrO2, Al2O3 and CeO2 coated with PDDS and all the coated
and non-coated nanoparticles were screened for antiplas-
modial activity against P. falciparum. The Al2O3 nanopar-
ticles (71.42 ± 0.49 lg ml-1) showed minimum level of
IC50 value and followed by MgO (72.33 ± 0.37 lg ml
-1)
and Fe3O4 nanoparticles (77.23 ± 0.42 lg ml
-1). The
PDDS-Fe3O4 showed minimum level of IC50 value (48.66 ±
0.45 lg ml-1), followed by PDDS-MgO (60.28 ± 0.42
lg ml-1) and PDDS-CeO2 (67.06 ± 0.61 lg ml
-1). The
PDDS-coated metal oxide nanoparticles showed superior
antiplasmodial activity than the non-PDDS-coated metal
oxide nanoparticles. Statistical analysis reveals that, signifi-
cant in vitro antiplasmodial activity (P \ 0.05) was observed
between the concentrations and time of exposure. The
chemical injury to erythrocytes showed no morphological
changes in erythrocytes by the nanoparticles after 48 h of
incubation. It is concluded from the present study that, the
PDDS-Fe3O4 showed good antiplasmodial activity and it
might be used for the development of antiplasmodial drugs.
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Introduction
Malaria caused by parasites of the genus Plasmodium, is
one of the leading public health problems in Sub-Saharan
Africa. It is estimated that malaria kills over a mil-
lion annually and some 3.2 billion people living in 107
countries or territories are at risk (WHO 2005). In Sub-
Saharan regions, 45 countries were endemic for malaria
in 2008 (WHO 2008). Artemisinin combination treat-
ments for falciparum malaria are currently the only first-
line antimalarial drugs amenable to widespread use
against all chloroquine-resistant malaria parasites (Barnes
and Folb 2003). However, artemisinin-resistant malaria
parasites were recently detected in Cambodia (Maude
et al. 2009). The newest antiplasmodial drugs from bio-
logical sources help in addressing this problem (Ravikumar
et al. 2011a, b, c, d, e) but it seems to be the loss of
biodiversity and cost effective. The nanoparticles posses
variety of biological activities (Martinez-Castanon et al.
2008; Lee et al. 2010; Singh et al. 2008) and considered
as a rich source of novel antiplasmodial agents and these
potential resources were scarcely explored. In the present
study, we report the findings of antiplasmodial poten-




Commercial nanoparticles of Al2O3, Fe3O4, CeO2, ZrO2,
and MgO were procured from Sigma Aldrich Company,
India. The characteristics of the nanoparticles are repre-
sented in Table 1.
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Parasite cultivation
The antiplasmodial activity of nanoparticles was assessed
against P. falciparum obtained from the Jawaharlal Nehru
Centre for Advanced Scientific Research, Bangalore, India.
P. falciparum are cultivated in human O Rh? red blood
cells using RPMI 1640 medium (HiMedia Laboratories
Private Limited, Mumbai, India) (Moore et al. 1967) sup-
plemented with O Rh? serum (10 %), 5 % sodium bicar-
bonate (HiMedia Laboratories Private Limited, Mumbai,
India) and 40 lg ml-1 of gentamicin sulfate (HiMedia
Laboratories Private Limited, Mumbai, India). Hematocrits
were adjusted at 5 % and parasite cultures were used when
they exhibited 2 % parasitaemia (Trager 1987).
In vitro antiplasmodial assay
Different concentrations of filter sterilized nanoparticles
(100, 50, 25, 12.5, 6.25 and 3.125 lg ml-1) were incor-
porated into 96-well tissue culture plate containing 200 ll
of P. falciparum culture with fresh red blood cells diluted
to 2 % hematocrit in triplicates. Negative control was
maintained with fresh red blood cells and 2 % parasitized
P. falciparum diluted to 2 % hematocrit, positive control
was maintained with parasitized blood cells culture treated
with chloroquine and artemether (Azas et al. 2001). Para-
sitaemia was evaluated after 48 h by Giemsa stain and the
average percentage suppression of parasitaemia was cal-
culated by the following formula: Average % suppression
of parasitaemia = Average % parasitaemia in control -
Average % parasitaemia in test/Average % parasitaemia in
control 9 100.
Antiplasmodial activity calculation and analysis
The antiplasmodial activities of nanoparticles were
expressed by the inhibitory concentrations (IC50) of the
drug that induced a 50 % reduction in parasitaemia com-
pared to the control (100 % parasitaemia). The IC50 values
were calculated (concentration of extract in X axis and
percentage of inhibition in Y axis), using Office XP (SDAS)
software with linear regression equation. This activity was
analyzed in accordance with the norms of antiplasmodial
activity of Rasoanaivo et al. (1992). According to this
norms, a nanoparticle is very active if IC50 \ 5 lg ml
-1,
active 5 lg ml-1 \ IC50 \ 50 lg ml
-1, weakly active
50 lg ml-1 \ IC50 \ 100 lg ml
-1 and inactive IC50 [
100 lg ml-1.
Chemical injury to erythrocytes
To assess any chemical injury to erythrocytes that might be
attributed to the nanoparticles, 200 ll of erythrocytes were
incubated with 100 lg ml-1 of the nanoparticles at a dose
equal to the highest used in the antiplasmodial assay. The
conditions of the experiment were maintained as in the case
of antiplasmodial assay. After 48 h of incubation, thin
blood smears were stained with Giemsa stain and observed for
morphological changes under high-power light microscopy.
The morphological findings were compared with those in
erythrocytes that were uninfected and not exposed to nano-
particles (Waako et al. 2007).
Results
A total of 11 samples were screened for antiplasmodial
activity and the IC50 values were represented in Table 2.
Among the metal oxide nanoparticles, Al2O3 (71.42 ±
0.49 lg ml-1) showed minimum level of IC50 value and
followed by MgO (72.33 ± 0.37 lg ml-1) and Fe3O4
(77.23 ± 0.42 lg ml-1). However, the PDDS-coated Fe3O4
showed minimum level of IC50 value (48.66 ± 0.45 lg ml
-1)








Al2O3 642991 101.96 Dispersion \50
CeO2 643009 172.11 Dispersion \25
Fe3O4 700312 231.53 Solution 9–11
ZrO2 643025 123.22 Powder \100
MgO 203718 40.30 Powder \30
Table 2 Antiplasmodial (IC50) activity of synthesised nanoparticles
Sample IC50 (lg ml
-1)
Al2O3 71.42 ± 0.49
CeO2 82.08 ± 0.51
Fe3O4 77.23 ± 0.42
ZrO2 81.11 ± 0.53
MgO 72.33 ± 0.37
PDDS-coated Al2O3 69.97 ± 0.46
PDDS-coated CeO2 67.06 ± 0.61
PDDS-coated Fe3O4 48.66 ± 0.45
PDDS-coated ZrO2 79.66 ± 0.49
PDDS-coated MgO 60.28 ± 0.42
PDDS 49.63 ± 0.38
Positive control
Chloroquine 19.59 ± 0.29
Artemether 4.09 ± 0.15
Values are found significant between concentrations and time of
exposure (P \ 0.05)
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and followed by PDDS-coated MgO (60.28 ± 0.42
lg ml-1) and CeO2 (67.06 ± 0.61 lg ml
-1). The PDDS
alone showed IC50 value of 49.63 ± 0.38 lg ml
-1 and the
PDDS-coated metal oxide nanoparticles showed better
antiplasmodial activity than the non-PDDS-coated metal
oxide nanoparticles. The microscopic observation of
uninfected erythrocytes added with all the test samples and
uninfected erythrocytes from the blank column of the
96-well plate showed no morphological differences after
48 h of incubation (Fig. 1).
Discussion
Metal nanoparticles have attracted much attention in the
fields of physics, chemistry, electronics and biology (Lanje
et al. 2010a; Schmid 1994; Henglein 1989) because of their
unique electrical (Peto et al. 2002), chemical (Kumar et al.
2003) and optical (Krolikowska et al. 2003) properties,
which are strongly dependent on the sizes and shapes of
metal nanomaterials (Creighton and Eadon 1991; Zhang
et al. 2000; Liu et al. 1995; Lanje et al. 2010a, b). Metal
nanoparticles have a high specific surface area and a high
surface-to-volume ratio. Nanostructured noble metals are
potentially used in catalysis, optoelectronics and micro-
electronics. Metal nanoparticles are particularly interesting
systems because of the ease with which they can be syn-
thesized and modified chemically (Ying et al. 2005).
However, the emergence of strains of P. falciparum
resistant to chloroquine and many other drugs in succession
and antimicrobial nature of nanoparticles has stimulated us
to identify new antiplasmodial agents from nanoparticles.
The present study has tested 10 nanoparticles samples
and a PDDS alone for antiplasmodial activity. Among the
10 nanoparticles, the PDDS-coated Fe3O4 showed mini-
mum level of IC50 value (48.66 ± 0.45 lg ml
-1) and
the concentration is 2.5-fold higher than the positive con-
trol chloroquine (19.59 ± 0.29 lg ml-1). According to
Rasoanaivo et al. (1992), 10 % of the nanoparticles used by
the present study are classified as active and 90 % of
the samples are classified as weakly active (Fig. 2). The
intracellular malarial parasite penetrates into the host red
blood cell membrane through new permeation pathways
(Go et al. 2004). It is already reported that, macromole-
cules like dextrans, protein A and IgG2a antibody also
gain access to react with the parasite through the new
permeation pathways (Pouvelle 1991). Foger et al. (2006)
reported that, the antisense nanoparticles inhibited the
malarial topoisomerase II in P. falciparum. The antisense
oligodeoxynucleotides inhibit the growth of parasites in a
non-specific manner by the polyanionic properties of oli-
gonucleotides which interfere with the merozoite invasion
into red blood cells (Noonpakdee et al. 2003; Barker et al.
1998). Moreover, the metal nanoparticles exhibited many
antimicrobial activities (Kvitek et al. 2008; Marini et al.
2007; Holt and Bard 2005). Smaller size nanoparticles
Fig. 1 Microscopical images of erythrocytes treated with synthesized
nanoparticles. a Al2O3-treated erythrocytes; b CeO2-treated erythro-
cytes; c Fe3O4-treated erythrocytes; d ZrO2-treated erythrocytes; e MgO-
treated erythrocytes; f PDDS-coated Al2O3-treated erythrocytes;
g PDDS-coated CeO2-treated erythrocytes; h PDDS coated Fe3O4-
treated erythrocytes; i PDDS-coated ZrO2-treated erythrocytes; j PDDS-
coated MgO-treated erythrocytes; k PDDS-treated erythrocytes;
l Uninfected and non-treated erythrocytes
Appl Nanosci (2013) 3:197–201 199
123
having the large surface area available for interaction and it
might be a one of the reason for better antiplasmodial
activity of PDDS-coated Fe3O4. It is concluded from the
present study that, the PDDS-coated Fe3O4 nanoparticles
could be used as an effective antiplasmodial agent for the
management of malaria after successful completion of in
vivo and clinical studies.
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